813 related articles for article (PubMed ID: 16127014)
1. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
Sapir T; Blank M; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
[TBL] [Abstract][Full Text] [Related]
2. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
Sapir T; Carp H; Shoenfeld Y
Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
[TBL] [Abstract][Full Text] [Related]
3. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
Hurez V; Kaveri SV; Kazatchkine MD
J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases].
Mouthon L; Hurez V; Kazatchkine M
Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation with intravenous immunoglobulin.
Hall PD
Pharmacotherapy; 1993; 13(6):564-73. PubMed ID: 8302679
[TBL] [Abstract][Full Text] [Related]
7. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
Rütter A; Luger TA
J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
[TBL] [Abstract][Full Text] [Related]
8. Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin.
Stricker RB; Winger EE
Am J Reprod Immunol; 2005 Dec; 54(6):390-6. PubMed ID: 16305665
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of intravenous immune globulin in immune-mediated diseases.
Mouthon L; Kaveri SV; Spalter SH; Lacroix-Desmazes S; Lefranc C; Desai R; Kazatchkine MD
Clin Exp Immunol; 1996 May; 104 Suppl 1():3-9. PubMed ID: 8625540
[TBL] [Abstract][Full Text] [Related]
10. IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients.
Shoenfeld Y; Katz U
Autoimmunity; 2005 Mar; 38(2):123-37. PubMed ID: 16040333
[TBL] [Abstract][Full Text] [Related]
11. Facing the enigma of immunomodulatory effects of intravenous immunoglobulin.
Sapir T; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):185-99. PubMed ID: 16391393
[TBL] [Abstract][Full Text] [Related]
12. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
Francioni C; Fioravanti A; Gelli R; Megale F; Marcolongo R
Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin therapy for autoimmune diseases.
Arnson Y; Shoenfeld Y; Amital H
Autoimmunity; 2009 Sep; 42(6):553-60. PubMed ID: 19657774
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
[TBL] [Abstract][Full Text] [Related]
15. Safety of intravenous immunoglobulin (IVIG) therapy.
Katz U; Achiron A; Sherer Y; Shoenfeld Y
Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
[TBL] [Abstract][Full Text] [Related]
16. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
Mouthon L; Kaveri S; Kazatchkine M
Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
[TBL] [Abstract][Full Text] [Related]
17. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
Jordan SC; Toyoda M
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
[TBL] [Abstract][Full Text] [Related]
18. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
Toubi E; Kessel A; Shoenfeld Y
Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
[TBL] [Abstract][Full Text] [Related]
19. Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss.
Konova E; Atanasova M; Stoykov S; Velkova A; Shoenfeld Y
J Autoimmun; 2007 Feb; 28(1):46-54. PubMed ID: 17178213
[TBL] [Abstract][Full Text] [Related]
20. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
Ballow M
J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]